Franck E. Nicolini
- Hematology top 0.2%
- Genetics top 0.2%
- Rheumatology top 0.5%
- Oncology top 5%
- Molecular Biology
- Co-authors
- Delphine RéaFrançois‐Xavier MahonLaurence LegrosFrançois GuilhotGabriel ÉtienneJoëlle GuilhotBruno VaretAude Charbonnier
- Topics
- Chronic Myeloid Leukemia Treatments (54 papers)Chronic Lymphocytic Leukemia Research (44 papers)Eosinophilic Disorders and Syndromes (28 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- FranceCanadaUnited States
In The Last Decade
Franck E. Nicolini
56 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Hematology 2.7k
- Genetics 2.1k
- Rheumatology 1.2k
- Oncology 501
- Molecular Biology 400
Countries citing papers authored by Franck E. Nicolini
This map shows the geographic impact of Franck E. Nicolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck E. Nicolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck E. Nicolini more than expected).
Fields of papers citing papers by Franck E. Nicolini
This network shows the impact of papers produced by Franck E. Nicolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck E. Nicolini. The network helps show where Franck E. Nicolini may publish in the future.
Co-authorship network of co-authors of Franck E. Nicolini
This figure shows the co-authorship network connecting the top 25 collaborators of Franck E. Nicolini. A scholar is included among the top collaborators of Franck E. Nicolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck E. Nicolini. Franck E. Nicolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 11 | |
| 3 | 6 | |
| 4 | 11 | |
| 5 | 15 | |
| 6 | 22 | |
| 7 | 171 | |
| 8 | 17 | |
| 9 | 28 | |
| 10 | 8 | |
| 11 | 370 | |
| 12 | 12 | |
| 13 | 46 | |
| 14 | 27 | |
| 15 | Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trialbreakdown → | 1046 |
| 16 | 4 | |
| 17 | 1 | |
| 18 | 15 | |
| 19 | 1 | |
| 20 | Stratégies thérapeutiques et recommandations pour la prise en charge des patients atteints de leucémie myéloïde chronique | 2 |
About Franck E. Nicolini
Franck E. Nicolini is a scholar working on Hematology, Genetics and Rheumatology, having authored 56 papers that have together received 3.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (54 papers), Chronic Lymphocytic Leukemia Research (44 papers) and Eosinophilic Disorders and Syndromes (28 papers). The work is most often cited by research in Hematology (2.7k citations), Genetics (2.1k citations) and Rheumatology (1.2k citations). Franck E. Nicolini has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Delphine Réa, François‐Xavier Mahon, Laurence Legros, François Guilhot, Gabriel Étienne, Joëlle Guilhot, Bruno Varet, Aude Charbonnier, Philippe Rousselot and Françoise Huguet. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.